EGF and rheumatoid arthritis: This evaluation score is called the multi-biomarkers disease activity test (MBDA), which determine the disease activity via biomarkers such as CRP, VCAM-1, IL-6, anti-MMP1 as well as EGF and VEGF-A, which give a better RA evaluation compared to the other test [114].